Clinical Trials
2 trialsNCT05671315 2023-05-25
A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients
Ruijin Hospital
Phase NA Unknown
NCT00746746 2011-01-13
A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma
Ochsner Health System
Phase 2 Unknown